In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott Moves One Way in Cardiovascular Devices, Another in Orthopedics, To Get To the Same Place

Executive Summary

Abbott Laboratories broke into the spinal market with its acquisition of Spinal Concepts, and expanded its interventional cardiology product line by acquiring Jomed's coronary and peripheral interventional product lines. Both deals reflect the increasing convergence in medical devices of drug and device therapies.
Advertisement

Related Content

Abbott Ventures: Extending Horizons in Abbott's Device Pipeline
Deal Statistics Quarterly, Q2 2003
Deal Statistics Quarterly, Q2 2003
Abbott Makes Its Play In Stents
Abbott: Cracking the Cardiology Cartel
Jomed's Global Positioning
Jomed Stakes Out the US
Jomed Goes Public, At Last
Jomed's Rising Star

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002133

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel